Keywords: داروهای ضد انعقاد; Catastrophic antiphospholipid syndrome; Antiphospholipid antibodies; Anticoagulant drugs; Plasma exchange; Corticosteroids; Intravenous immunoglobulins;
مقالات ISI داروهای ضد انعقاد (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: داروهای ضد انعقاد; Deep Vein Thrombosis; Anticoagulant drugs; Thrombolytic therapy; Mechanical thrombolysis; Rivaroxaban; Apixaban; Edoxaban; Dabigatran; Warfarin;
Keywords: داروهای ضد انعقاد; Venous thromboembolism; Gender; Cancer; Anticoagulant drugs; Recurrence; Hemorrhage; Mortality;
Keywords: داروهای ضد انعقاد; anticoagulant drugs; atrial fibrillation; cardiac remodeling; fibrosis; inflammation; thromboembolism;
Keywords: داروهای ضد انعقاد; Anticoagulant drugs; Hemorrhage; Hip prosthesis; Treatment Effectiveness; Venous Thromboembolism;
Keywords: داروهای ضد انعقاد; Gastrointestinal bleeding; Therapeutic context; Patient characteristics; Co-morbidities; Anticoagulant drugs;
Keywords: داروهای ضد انعقاد; Antiaggregant drugs; Anticoagulant drugs; Cardioprotection; Ischemia–reperfusion injury; Renoprotection
Keywords: داروهای ضد انعقاد; anticoagulant drugs; pulmonary embolism; total knee arthroplasty; venous thromboembolism
Keywords: داروهای ضد انعقاد; Anticoagulant drugs; Pregnancy; Anesthesia; Obstetrical;
Original ResearchThe early prevention and treatment of PVST after laparoscopic splenectomy: A prospective cohort study of 130 patients
Keywords: داروهای ضد انعقاد; PVST; Anticoagulant drugs; Laparoscopic splenectomy; Risk factors;
Prevalencia de la anticoagulación oral y calidad de su seguimiento en el ámbito de la atención primaria: estudio de la Red Centinela Sanitaria de la Comunitat Valenciana
Keywords: داروهای ضد انعقاد; Fármacos anticoagulantes; Prevalencia; Evaluación de la calidad de atención sanitaria; Vigilancia centinela; Atención primaria; Historia clÃnica electrónica; Anticoagulant drugs; Prevalence; Healthcare quality assessment; Sentinel surveillance; Prim
Inadequate anticoagulation by Vitamin K Antagonists is associated with Major Adverse Cardiovascular Events in patients with atrial fibrillation
Keywords: داروهای ضد انعقاد; Atrial fibrillation; Myocardial infarction; Warfarin; Anticoagulant drugs; Cardiovascular diseases;
Ãtude rétrospective évaluant les risques hémorragiques et thromboemboliques lors d'avulsions dentaires chez 93 patients habituellement traités par AVK et/ou AAP
Keywords: داروهای ضد انعقاد; Avulsion dentaire; Anticoagulants; Antiagrégants plaquettaires; Hémorragie; Risque thromboembolique; Tooth extraction; Anticoagulant drugs; Platelet aggregation inhibitor; Hemorrhage; Thromboembolic risk;
Heparin dosing in critically ill patients undergoing therapeutic hypothermia following cardiac arrest
Keywords: داروهای ضد انعقاد; Heparin; Anticoagulant drugs; Hypothermia; Cardiopulmonary arrest; Dose-response relationship; Drug;
A comparative study of conventional versus new, magnesium-poor Vacutainer® Sodium Citrate blood collection tubes for determination of prothrombin time and INR
Keywords: داروهای ضد انعقاد; Blood specimen collection; Prothrombin Time; Anticoagulant drugs; Therapeutic drug monitoring; Magnesium;
Protocols of antithrombotic therapy in a University Cardiocenter
Keywords: داروهای ضد انعقاد; Antithrombotic therapy; Anticoagulant drugs; Antiaggregation drugs; Acute coronary syndrome; Percutaneous coronary intervention; Atrial fibrillation; Thromboembolic disease; Coronary artery bypass graft surgery;
Use of vitamin K antagonists and risk of subarachnoid haemorrhage: A population-based case-control study
Keywords: داروهای ضد انعقاد; Subarachnoid haemorrhage; Anticoagulant drugs; Warfarin; Population-based; Risk; Drug toxicity
Fatal intoxications by acenocoumarol, phenprocoumon and warfarin: Method validation in blood using the total error approach
Keywords: داروهای ضد انعقاد; Anticoagulant drugs; HPLC; Total error
Is thrombin generation the new rapid, reliable and relevant pharmacological tool for the development of anticoagulant drugs?
Keywords: داروهای ضد انعقاد; Thrombin; Thrombin generation; Thrombin activity profile; Anticoagulant drugs
Anticoagulants et anti-agrégants en traumatologie crânienne et rachidienne
Keywords: داروهای ضد انعقاد; Anticoagulants; Anti-agrégants; Traumatismes crâniens; Traumatismes rachidien; Anticoagulant drugs; Antiplatelet drugs; Head injuries; Spinal cord injuries;
Acute ST-Segment Elevation Myocardial Infarction : American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
Keywords: داروهای ضد انعقاد; anticoagulant drugs; antiplatelet drugs; fibrinolytic therapy; myocardial infarction
How Frequently Is Venous Thromboembolism in Heparin-Treated Patients Associated With Heparin-Induced Thrombocytopenia?
Keywords: داروهای ضد انعقاد; adverse effects; anticoagulant drugs; heparin; thrombocytopenia; thrombosis; venous thrombosis
AFFIRMÂ : ce que nous avons appris... et les questions en suspens
Keywords: داروهای ضد انعقاد; Fibrillation atriale; médicaments antiarythmiques; médicaments anticoagulants; Atrial fibrillation; antiarrhythmic drugs; anticoagulant drugs;
Effect of a Centralized Clinical Pharmacy Anticoagulation Service on the Outcomes of Anticoagulation Therapy
Keywords: داروهای ضد انعقاد; anticoagulant drugs; health-care quality assessment; pharmacists; AMS; anticoagulation management service; CPAS; clinical pharmacy anticoagulation service; DVT; deep vein thrombosis; HMO; health maintenance organization; ICD-9; International Classificatio